Purdue Pharma has been sentenced to pay over $5 billion for its role in the opioid epidemic. It is a landmark moment. It is also, for hundreds of thousands of families, nowhere near enough.
On April 28, 2026, a federal court in Newark, New Jersey sentenced Purdue Pharma LP to pay more than $5 billion in criminal penalties; the culmination of a years-long legal reckoning with a company that, by the government’s own account, put profits over patient health and safety and helped fuel one of the deadliest public health crises in American history.
The sentence is significant. It is historic. But for anyone who has spent time with the full, devastating arc of the opioid epidemic, and I mean really spent time with it, the way Sam Quinones did in his landmark book Dreamland, it is impossible to feel real closure.
What Purdue Did And What It Knew
Between 2007 and 2017, according to the DOJ Press Release and federal court documents, Purdue Pharma “callously focused on profits” and systematically marketed its opioid products to hundreds of providers that the company “knew” were writing prescriptions without a legitimate medical purpose. It wasn’t ignorance. It wasn’t negligence. It was, as the DOJ noted, a calculated decision to prioritize profits over human life, to look the other way, and then to forge ahead with misleading and untruthful claims, coupled with incentives designed to keep providers prescribing highly addictive drugs that led to the deaths of hundreds of thousands of people.
The Press Release also notes that Purdue defrauded the Drug Enforcement Administration by misrepresenting the effectiveness of its own anti-diversion programs. It used prescriptions from those very same problematic prescribers to justify requests to the DEA to increase its manufacturing quotas. And to keep the pipeline full, the Press Release goes on to say, it paid kickbacks through a doctor speaker program and through an electronic health records platform to incentivize physicians to prescribe more of its addictive products.
Purdue pleaded guilty in November 2020 to a three-count felony information, including conspiracy to defraud the United States and two counts of conspiracy to violate the Federal Anti-Kickback Statute. Yesterday’s sentencing brings that legal chapter to its formal close.
The court ordered Purdue to pay a criminal fine of $3.544 billion and an additional $2 billion in criminal forfeiture. Notably, up to $1.775 billion of that forfeiture amount may be credited if Purdue ceases to operate in its current form and emerges from bankruptcy as a public benefit company, one whose proceeds are directed toward state and local opioid abatement programs. The company is also required to maintain a public document repository related to the criminal charges, a provision that matters enormously for transparency and accountability going forward.
The Human Cost Behind the Headlines
Legal proceedings have a way of abstracting suffering into dollar amounts and felony counts. The numbers above are staggering in financial terms. But they exist in a different universe from the human accounting of this crisis.
The opioid epidemic with prescription painkillers as its first, devastating wave has claimed hundreds of thousands of American lives over the past three decades. It hollowed out communities, overwhelmed emergency rooms, shattered families, and paved the way for the fentanyl crisis that continues to kill tens of thousands of people every year. DEA Administrator Terrance Cole said it plainly in his sentencing remarks: the prescription opioid epidemic directly paved the way for today’s fentanyl crisis.
No fine reverses that. No forfeiture brings anyone back.
If you want to understand the opioid crisis at a human level, not as a corporate scandal or a policy failure, but as a tragedy that unfolded one family, one town, one prescription at a time, read Sam Quinones’s book, Dreamland. Published in 2015, it remains for me the definitive account of how America became addicted; tracing the simultaneous rise of OxyContin marketing, the pharmaceutical industry’s campaign to reframe addiction, and the networks of small-town dealers who moved into the vacuum that pills created. It is reported with extraordinary empathy and rigor. It names names. And it forces the reader to confront a simple, devastating truth: that this was not an accident. It was the predictable result of choices made by people who knew exactly what they were doing.
Accountability Matters And So Does Memory
I want to be careful not to dismiss the significance of yesterday’s sentencing. Corporate criminal accountability at this scale is rare. The Department of Justice, the FBI, the DEA, and HHS-OIG spent years building this case, and the outcome reflects real institutional commitment. Assistant Attorney General A. Tysen Duva called it “one of the most important corporate enforcement cases ever brought by the Department of Justice,” and that is not an exaggeration.
The requirement that Purdue potentially emerge from bankruptcy as a public benefit company (one legally oriented toward public good rather than shareholder profit) is also worth watching carefully. If it happens, and if the proceeds genuinely flow toward addiction treatment and community recovery, there is at least a path toward some of this money doing meaningful work.
But accountability without memory is incomplete. And memory without structural change is insufficient.
The pharmaceutical industry, the medical establishment, and the regulatory systems that allowed this to unfold over decades are still largely intact. The cultural and political forces that made it easy to flood vulnerable communities with pills and hard to get anyone treatment have not disappeared. The fentanyl crisis is, right now, claiming lives at staggering rates..
What We Owe the People Who Didn’t Make It Out
Read Dreamland. Not as a historical document, but as a living one. The people in those pages; the teenagers in Portsmouth, Ohio; the parents in small towns across New Mexico and Kentucky and West Virginia; the doctors who were deceived and the ones who chose not to look… they are not abstractions. They are us, or they are people we know, or they are people whose stories deserve to be held with the same seriousness that we hold balance sheets and felony counts.
Purdue Pharma has been sentenced. Justice, of a kind, has been served.
Now comes the harder, longer, less newsworthy work: rebuilding what was broken, funding what was defunded, and making sure we never again allow profit to be protected at the cost of people’s lives.
That part doesn’t end with a sentencing. It’s just beginning.